Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.61 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29577299 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL1285953 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL2701578 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL30168486 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL8389087 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL11221318 | 1.00 | PRKCA (0.61) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL6565430 | 0.99 | PRKCA (0.59) | PRKCAPRKCEPRKCQPRKCDFAAH | |
| SCHEMBL14957317 | 0.93 | PRKCA (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL6324925 | 0.93 | PRKCA (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL31326010 | 0.92 | PRKCA (0.60) | PRKCAPRKCEPRKCQPRKCDFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118973615-A | Lipid nanoparticles for delivering nucleic acid to peripheral blood mononuclear cells and methods of using the same | 日油株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-118574607-A | Surface-modified plant-derived extracellular vesicles and targeted drug delivery vehicles using the same | 韩国科学技术研究院 | 2024-08-30 | — | — | CN | claimed |
| CN-118973615-A | Lipid nanoparticles for delivering nucleic acid to peripheral blood mononuclear cells and methods of using the same | 日油株式会社 | 2024-11-15 | — | — | CN | disclosed |
| CN-110709065-B | Fusogenic liposomes, compositions, kits and uses thereof for treating cancer | APA先进技术有限公司 | 2023-02-10 | — | — | CN | disclosed |
| CN-110636836-B | P-ethoxy nucleic acids for STAT3 inhibition | 拜奥-帕斯控股股份有限公司 | 2022-12-16 | — | — | CN | disclosed |
| US-10670578-B2 | Controlling translocation through nanopores with fluid walls | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-06-02 | — | — | US | disclosed |
| US-20190234930-A1 | Controlling Translocation Through Nanopores With Fluid Walls | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-08-01 | — | — | US | disclosed |
| US-10254271-B2 | Controlling translocation through nanopores with fluid walls | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170023544-A1 | CONTROLLING TRANSLOCATION THROUGH NANOPORES WITH FLUID WALLS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2017-01-26 | — | — | US | disclosed |
| US-9347929-B2 | Controlling translocation through nanopores with fluid wall | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-05-24 | — | — | US | disclosed |
| US-20130048499-A1 | CONTROLLING TRANSLOCATION THROUGH NANOPORES WITH FLUID WALL | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2013-02-28 | — | — | US | disclosed |